Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Susan J Ramus
  • Christiana Kartsonaki
  • Simon A Gayther
  • Paul D P Pharoah
  • Olga M Sinilnikova
  • Jonathan Beesley
  • Xiaoqing Chen
  • Lesley McGuffog
  • Sue Healey
  • Fergus J Couch
  • Xianshu Wang
  • Zachary Fredericksen
  • Paolo Peterlongo
  • Siranoush Manoukian
  • Bernard Peissel
  • Daniela Zaffaroni
  • Gaia Roversi
  • Monica Barile
  • Alessandra Viel
  • Anna Allavena
  • Laura Ottini
  • Laura Papi
  • Viviana Gismondi
  • Fabio Capra
  • Paolo Radice
  • Mark H Greene
  • Phuong L Mai
  • Irene L Andrulis
  • Gord Glendon
  • Hilmi Ozcelik
  • Mads Thomassen
  • Anne-Marie Gerdes
  • Torben A Kruse
  • Dorthe Cruger
  • Uffe Birk Jensen
  • Maria Adelaide Caligo
  • Håkan Olsson
  • Ulf Kristoffersson
  • Annika Lindblom
  • Brita Arver
  • Per W. Karlsson
  • Marie Stenmark Askmalm
  • Ake Borg
  • Susan L Neuhausen
  • Yuan Chun Ding
  • Katherine L Nathanson
  • Susan M Domchek
  • Thomas v O Hansen
  • Lars Jønson
  • Bent Ejlertsen
  • OCGN
Vis graf over relationer
Germline mutations in the BRCA1 and BRCA2 genes are associated with increased risks of breast and ovarian cancers. Although several common variants have been associated with breast cancer susceptibility in mutation carriers, none have been associated with ovarian cancer susceptibility. A genome-wide association study recently identified an association between the rare allele of the single-nucleotide polymorphism (SNP) rs3814113 (ie, the C allele) at 9p22.2 and decreased risk of ovarian cancer for women in the general population. We evaluated the association of this SNP with ovarian cancer risk among BRCA1 or BRCA2 mutation carriers by use of data from the Consortium of Investigators of Modifiers of BRCA1/2.
OriginalsprogEngelsk
TidsskriftNational Cancer Institute. Journal (Print)
Vol/bind103
Udgave nummer2
Sider (fra-til)105-16
Antal sider12
ISSN0027-8874
DOI
StatusUdgivet - 2011

ID: 33217758